A bill to improve the systems for identifying the diversion of controlled substances.

United States115th CongressS-2837Senate
Updated: Jun 19, 2018

Summary

Preventing Drug Diversion Act of 2018 This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion. Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners. Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.

Bill texts

Available versions
View official text

2 versions available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on the Judiciary.

    Senate

  2. Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Senate

  3. Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.

    Senate

  4. Placed on Senate Legislative Calendar under General Orders. Calendar No. 471.

    Senate